Soraya Rofagha, Robert B Bhisitkul, David S Boyer, SriniVas R Sadda, Kang Zhang. Ophthalmology 2013
Times Cited: 649
Times Cited: 649
Times Cited
Times Co-cited
Similarity
Ranibizumab for neovascular age-related macular degeneration.
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
47
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Jeffrey S Heier, David M Brown, Victor Chong, Jean-Francois Korobelnik, Peter K Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D Yancopoulos,[...]. Ophthalmology 2012
Jeffrey S Heier, David M Brown, Victor Chong, Jean-Francois Korobelnik, Peter K Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D Yancopoulos,[...]. Ophthalmology 2012
36
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
Maureen G Maguire, Daniel F Martin, Gui-Shuang Ying, Glenn J Jaffe, Ebenezer Daniel, Juan E Grunwald, Cynthia A Toth, Frederick L Ferris, Stuart L Fine. Ophthalmology 2016
Maureen G Maguire, Daniel F Martin, Gui-Shuang Ying, Glenn J Jaffe, Ebenezer Daniel, Juan E Grunwald, Cynthia A Toth, Frederick L Ferris, Stuart L Fine. Ophthalmology 2016
28
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider. N Engl J Med 2006
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider. N Engl J Med 2006
26
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris. Ophthalmology 2012
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris. Ophthalmology 2012
20
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Daniel F Martin, Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe. N Engl J Med 2011
Daniel F Martin, Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe. N Engl J Med 2011
20
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Quan Dong Nguyen, Allen C Ho, Yuichiro Ogura, Christian Simader, Glenn J Jaffe,[...]. Ophthalmology 2014
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Quan Dong Nguyen, Allen C Ho, Yuichiro Ogura, Christian Simader, Glenn J Jaffe,[...]. Ophthalmology 2014
19
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev. Ophthalmology 2009
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev. Ophthalmology 2009
18
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Pravin U Dugel, Adrian Koh, Yuichiro Ogura, Glenn J Jaffe, Ursula Schmidt-Erfurth, David M Brown, Andre V Gomes, James Warburton, Andreas Weichselberger, Frank G Holz. Ophthalmology 2020
Pravin U Dugel, Adrian Koh, Yuichiro Ogura, Glenn J Jaffe, Ursula Schmidt-Erfurth, David M Brown, Andre V Gomes, James Warburton, Andreas Weichselberger, Frank G Holz. Ophthalmology 2020
18
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Wan Ling Wong, Xinyi Su, Xiang Li, Chui Ming G Cheung, Ronald Klein, Ching-Yu Cheng, Tien Yin Wong. Lancet Glob Health 2014
Wan Ling Wong, Xinyi Su, Xiang Li, Chui Ming G Cheung, Ronald Klein, Ching-Yu Cheng, Tien Yin Wong. Lancet Glob Health 2014
17
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Rafael Cortez, Carel B Hoyng, Philip Hykin, Giovanni Staurenghi, Stephanie Heldner,[...]. Br J Ophthalmol 2015
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Rafael Cortez, Carel B Hoyng, Philip Hykin, Giovanni Staurenghi, Stephanie Heldner,[...]. Br J Ophthalmol 2015
16
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
Mark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor. Ophthalmology 2015
Mark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor. Ophthalmology 2015
16
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.
Michael A Singer, Carl C Awh, SriniVas Sadda, William R Freeman, Andrew N Antoszyk, Pamela Wong, Lisa Tuomi. Ophthalmology 2012
Michael A Singer, Carl C Awh, SriniVas Sadda, William R Freeman, Andrew N Antoszyk, Pamela Wong, Lisa Tuomi. Ophthalmology 2012
15
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Lucy A Culliford, Barnaby C Reeves. Lancet 2013
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Lucy A Culliford, Barnaby C Reeves. Lancet 2013
12
Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.
Srinivas R Sadda, Robyn Guymer, Frank G Holz, Steffen Schmitz-Valckenberg, Christine A Curcio, Alan C Bird, Barbara A Blodi, Ferdinando Bottoni, Usha Chakravarthy, Emily Y Chew,[...]. Ophthalmology 2018
Srinivas R Sadda, Robyn Guymer, Frank G Holz, Steffen Schmitz-Valckenberg, Christine A Curcio, Alan C Bird, Barbara A Blodi, Ferdinando Bottoni, Usha Chakravarthy, Emily Y Chew,[...]. Ophthalmology 2018
11
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions.
Mark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel Barthelmes. Am J Ophthalmol 2020
Mark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel Barthelmes. Am J Ophthalmol 2020
29
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group.
Richard F Spaide, Glenn J Jaffe, David Sarraf, K Bailey Freund, Srinivas R Sadda, Giovanni Staurenghi, Nadia K Waheed, Usha Chakravarthy, Philip J Rosenfeld, Frank G Holz,[...]. Ophthalmology 2020
Richard F Spaide, Glenn J Jaffe, David Sarraf, K Bailey Freund, Srinivas R Sadda, Giovanni Staurenghi, Nadia K Waheed, Usha Chakravarthy, Philip J Rosenfeld, Frank G Holz,[...]. Ophthalmology 2020
10
Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
SriniVas R Sadda, Lisa L Tuomi, Beiying Ding, Anne E Fung, J Jill Hopkins. Ophthalmology 2018
SriniVas R Sadda, Lisa L Tuomi, Beiying Ding, Anne E Fung, J Jill Hopkins. Ophthalmology 2018
12
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, Gui-Shuang Ying, Wei Pan, Glenn J Jaffe, Cynthia A Toth, Stephanie A Hagstrom, Maureen G Maguire, Daniel F Martin. Ophthalmology 2017
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, Gui-Shuang Ying, Wei Pan, Glenn J Jaffe, Cynthia A Toth, Stephanie A Hagstrom, Maureen G Maguire, Daniel F Martin. Ophthalmology 2017
9
Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degeneration.
Marc C Peden, Ivan J Suñer, Mark E Hammer, W Sanderson Grizzard. Ophthalmology 2015
Marc C Peden, Ivan J Suñer, Mark E Hammer, W Sanderson Grizzard. Ophthalmology 2015
9
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.
Tien Y Wong, Usha Chakravarthy, Ronald Klein, Paul Mitchell, Gergana Zlateva, Ronald Buggage, Kyle Fahrbach, Corey Probst, Isabella Sledge. Ophthalmology 2008
Tien Y Wong, Usha Chakravarthy, Ronald Klein, Paul Mitchell, Gergana Zlateva, Ronald Buggage, Kyle Fahrbach, Corey Probst, Isabella Sledge. Ophthalmology 2008
9
Clinical classification of age-related macular degeneration.
Frederick L Ferris, C P Wilkinson, Alan Bird, Usha Chakravarthy, Emily Chew, Karl Csaky, SriniVas R Sadda. Ophthalmology 2013
Frederick L Ferris, C P Wilkinson, Alan Bird, Usha Chakravarthy, Emily Chew, Karl Csaky, SriniVas R Sadda. Ophthalmology 2013
9
Risk of scar in the comparison of age-related macular degeneration treatments trials.
Ebenezer Daniel, Cynthia A Toth, Juan E Grunwald, Glenn J Jaffe, Daniel F Martin, Stuart L Fine, Jiayan Huang, Gui-shuang Ying, Stephanie A Hagstrom, Katrina Winter,[...]. Ophthalmology 2014
Ebenezer Daniel, Cynthia A Toth, Juan E Grunwald, Glenn J Jaffe, Daniel F Martin, Stuart L Fine, Jiayan Huang, Gui-shuang Ying, Stephanie A Hagstrom, Katrina Winter,[...]. Ophthalmology 2014
8
METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Leah N Kim, Hemal Mehta, Daniel Barthelmes, Vuong Nguyen, Mark C Gillies. Retina 2016
Leah N Kim, Hemal Mehta, Daniel Barthelmes, Vuong Nguyen, Mark C Gillies. Retina 2016
8
Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration.
Shruti Chandra, Cristina Arpa, Deepthy Menon, Hagar Khalid, Robin Hamilton, Luke Nicholson, Bishwanath Pal, Sandro Fasolo, Philip Hykin, Pearse A Keane,[...]. Eye (Lond) 2020
Shruti Chandra, Cristina Arpa, Deepthy Menon, Hagar Khalid, Robin Hamilton, Luke Nicholson, Bishwanath Pal, Sandro Fasolo, Philip Hykin, Pearse A Keane,[...]. Eye (Lond) 2020
25
Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study.
Robert B Bhisitkul, Thais S Mendes, Soraya Rofagha, Wayne Enanoria, David S Boyer, SriniVas R Sadda, Kang Zhang. Am J Ophthalmol 2015
Robert B Bhisitkul, Thais S Mendes, Soraya Rofagha, Wayne Enanoria, David S Boyer, SriniVas R Sadda, Kang Zhang. Am J Ophthalmol 2015
8
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.
Lars G Fritsche, Wilmar Igl, Jessica N Cooke Bailey, Felix Grassmann, Sebanti Sengupta, Jennifer L Bragg-Gresham, Kathryn P Burdon, Scott J Hebbring, Cindy Wen, Mathias Gorski,[...]. Nat Genet 2016
Lars G Fritsche, Wilmar Igl, Jessica N Cooke Bailey, Felix Grassmann, Sebanti Sengupta, Jennifer L Bragg-Gresham, Kathryn P Burdon, Scott J Hebbring, Cindy Wen, Mathias Gorski,[...]. Nat Genet 2016
8
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
Frank G Holz, Srinivas R Sadda, Brandon Busbee, Emily Y Chew, Paul Mitchell, Adnan Tufail, Christopher Brittain, Daniela Ferrara, Sarah Gray, Lee Honigberg,[...]. JAMA Ophthalmol 2018
Frank G Holz, Srinivas R Sadda, Brandon Busbee, Emily Y Chew, Paul Mitchell, Adnan Tufail, Christopher Brittain, Daniela Ferrara, Sarah Gray, Lee Honigberg,[...]. JAMA Ophthalmol 2018
8
Long-term Outcome of Intravitreal Aflibercept Treatment for Neovascular Age-Related Macular Degeneration Using a "Treat-and-Extend" Regimen.
Peter G Traine, Isabel B Pfister, Souska Zandi, Jan Spindler, Justus G Garweg. Ophthalmol Retina 2019
Peter G Traine, Isabel B Pfister, Souska Zandi, Jan Spindler, Justus G Garweg. Ophthalmol Retina 2019
18
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes.
Thomas A Ciulla, Rehan M Hussain, John S Pollack, David F Williams. Ophthalmol Retina 2020
Thomas A Ciulla, Rehan M Hussain, John S Pollack, David F Williams. Ophthalmol Retina 2020
14
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard, Francesco Bandello. Br J Ophthalmol 2014
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard, Francesco Bandello. Br J Ophthalmol 2014
7
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR : A Randomized Controlled Trial.
Masahito Ohji, Kanji Takahashi, Annabelle A Okada, Masato Kobayashi, Yoshimi Matsuda, Yasuhiro Terano. Adv Ther 2020
Masahito Ohji, Kanji Takahashi, Annabelle A Okada, Masato Kobayashi, Yoshimi Matsuda, Yasuhiro Terano. Adv Ther 2020
8
Age-related macular degeneration.
Paul Mitchell, Gerald Liew, Bamini Gopinath, Tien Y Wong. Lancet 2018
Paul Mitchell, Gerald Liew, Bamini Gopinath, Tien Y Wong. Lancet 2018
7
Age-related macular degeneration.
Laurence S Lim, Paul Mitchell, Johanna M Seddon, Frank G Holz, Tien Y Wong. Lancet 2012
Laurence S Lim, Paul Mitchell, Johanna M Seddon, Frank G Holz, Tien Y Wong. Lancet 2012
7
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Geeta A Lalwani, Philip J Rosenfeld, Anne E Fung, Sander R Dubovy, Stephen Michels, William Feuer, Janet L Davis, Harry W Flynn, Maria Esquiabro. Am J Ophthalmol 2009
Geeta A Lalwani, Philip J Rosenfeld, Anne E Fung, Sander R Dubovy, Stephen Michels, William Feuer, Janet L Davis, Harry W Flynn, Maria Esquiabro. Am J Ophthalmol 2009
7
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
. Arch Ophthalmol 2001
. Arch Ophthalmol 2001
7
Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients.
Christoph Ehlken, Mandy Helms, Daniel Böhringer, Hansjürgen T Agostini, Andreas Stahl. Clin Ophthalmol 2017
Christoph Ehlken, Mandy Helms, Daniel Böhringer, Hansjürgen T Agostini, Andreas Stahl. Clin Ophthalmol 2017
8
Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol.
Karina Berg, Terje R Pedersen, Leiv Sandvik, Ragnheiður Bragadóttir. Ophthalmology 2015
Karina Berg, Terje R Pedersen, Leiv Sandvik, Ragnheiður Bragadóttir. Ophthalmology 2015
6
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Gui-shuang Ying, Jiayan Huang, Maureen G Maguire, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Ebenezer Daniel, Michael Klein, Dante Pieramici, John Wells,[...]. Ophthalmology 2013
Gui-shuang Ying, Jiayan Huang, Maureen G Maguire, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Ebenezer Daniel, Michael Klein, Dante Pieramici, John Wells,[...]. Ophthalmology 2013
6
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.
Ursula Schmidt-Erfurth, Sebastian M Waldstein. Prog Retin Eye Res 2016
Ursula Schmidt-Erfurth, Sebastian M Waldstein. Prog Retin Eye Res 2016
6
TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Daniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold,[...]. Retina 2018
Daniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold,[...]. Retina 2018
8
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.
Robyn H Guymer, Caroline M Markey, Ian L McAllister, Mark C Gillies, Alex P Hunyor, Jennifer J Arnold. Ophthalmology 2019
Robyn H Guymer, Caroline M Markey, Ian L McAllister, Mark C Gillies, Alex P Hunyor, Jennifer J Arnold. Ophthalmology 2019
6
Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting.
E Boulanger-Scemama, G Querques, F About, N Puche, M Srour, V Mane, N Massamba, F Canoui-Poitrine, E H Souied. J Fr Ophtalmol 2015
E Boulanger-Scemama, G Querques, F About, N Puche, M Srour, V Mane, N Massamba, F Canoui-Poitrine, E H Souied. J Fr Ophtalmol 2015
9
TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
Matthew R Starr, Felix F Kung, Camilo A Mejia, Yvonne T Bui, Sophie J Bakri. Retina 2020
Matthew R Starr, Felix F Kung, Camilo A Mejia, Yvonne T Bui, Sophie J Bakri. Retina 2020
60
Consistent Long-Term Therapy of Neovascular Age-Related Macular Degeneration Managed by 50 or More Anti-VEGF Injections Using a Treat-Extend-Stop Protocol.
Sean D Adrean, Siyang Chaili, Hema Ramkumar, Ash Pirouz, Scott Grant. Ophthalmology 2018
Sean D Adrean, Siyang Chaili, Hema Ramkumar, Ash Pirouz, Scott Grant. Ophthalmology 2018
15
An 8-year follow-up of anti-vascular endothelial growth factor treatment with a treat-and-extend modality for neovascular age-related macular degeneration.
Karina Berg, Anca B Roald, Jesintha Navaratnam, Ragnheiður Bragadóttir. Acta Ophthalmol 2017
Karina Berg, Anca B Roald, Jesintha Navaratnam, Ragnheiður Bragadóttir. Acta Ophthalmol 2017
13
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Ebenezer Daniel, Wei Pan, Gui-Shuang Ying, Benjamin J Kim, Juan E Grunwald, Frederick L Ferris, Glenn J Jaffe, Cynthia A Toth, Daniel F Martin, Stuart L Fine,[...]. Ophthalmology 2018
Ebenezer Daniel, Wei Pan, Gui-Shuang Ying, Benjamin J Kim, Juan E Grunwald, Frederick L Ferris, Glenn J Jaffe, Cynthia A Toth, Daniel F Martin, Stuart L Fine,[...]. Ophthalmology 2018
17
Novel method for analyzing snellen visual acuity measurements.
Ninel Z Gregori, William Feuer, Philip J Rosenfeld. Retina 2010
Ninel Z Gregori, William Feuer, Philip J Rosenfeld. Retina 2010
6
Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors.
Hemal Mehta, Adnan Tufail, Vincent Daien, Aaron Y Lee, Vuong Nguyen, Mehmet Ozturk, Daniel Barthelmes, Mark C Gillies. Prog Retin Eye Res 2018
Hemal Mehta, Adnan Tufail, Vincent Daien, Aaron Y Lee, Vuong Nguyen, Mehmet Ozturk, Daniel Barthelmes, Mark C Gillies. Prog Retin Eye Res 2018
6
Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
Glenn J Jaffe, Gui-Shuang Ying, Cynthia A Toth, Ebenezer Daniel, Juan E Grunwald, Daniel F Martin, Maureen G Maguire. Ophthalmology 2019
Glenn J Jaffe, Gui-Shuang Ying, Cynthia A Toth, Ebenezer Daniel, Juan E Grunwald, Daniel F Martin, Maureen G Maguire. Ophthalmology 2019
6
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.